Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)

Phase Distribution

Ph not_applicable
3
60%
Ph phase_4
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (40.0%)
N/A3 (60.0%)

Trials by Status

unknown120%
completed360%
withdrawn120%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
PROCEDURE
Total Trials
5